# Blended Resources for Integrated Diabetes Guidance and Empowerment

Study · id `cardio:ct-nct07373379` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07373379](<https://clinicaltrials.gov/study/NCT07373379>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07373379

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT07373379. Randomized; single masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2026-03-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT07373379, source copy `cardio:ctgov-nct07373379-2026-02-23`, retrieved 2026-10-26)
- Planned start: 2026-03-01 (anticipated) (ClinicalTrials.gov record NCT07373379, source copy `cardio:ctgov-nct07373379-2026-02-23`, retrieved 2026-10-26)
- Primary completion: 2026-03-01 (anticipated) (ClinicalTrials.gov record NCT07373379, source copy `cardio:ctgov-nct07373379-2026-02-23`, retrieved 2026-10-26)
- Completion: 2026-10-30 (anticipated) (ClinicalTrials.gov record NCT07373379, source copy `cardio:ctgov-nct07373379-2026-02-23`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07373379-2026-02-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Blended Resources for Integrated Diabetes Guidance and Empowerment
- Acronym: BRIDGE
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): AI-driven Dietary Management and Human-in-the-loop Support
- Lead sponsor: Peking University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Peking University (`cardio:org-peking-university`)

## Provenance

Content hash: c8ddd861c94f5c5427accb0cd407e6d39221d90ad5907461401f3bc3120b1d7e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
